{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T01:05:22Z","timestamp":1793927122137,"version":"4.8.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T00:00:00Z","timestamp":1767052800000},"content-version":"vor","delay-in-days":33,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-28927-1","type":"journal-article","created":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T12:27:45Z","timestamp":1764246465000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Wearable inertial device for monitoring Parkinson\u2019s disease symptoms: a pilot study in a controlled environment"],"prefix":"10.1038","volume":"15","author":[{"given":"Margaux","family":"Poleur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Gidaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Delstanche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Marc","family":"Gurruchaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Tricot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e9opold","family":"Bancel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Palfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Servais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Degos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,27]]},"reference":[{"key":"28927_CR1","doi-asserted-by":"publisher","first-page":"a033118","DOI":"10.1101\/cshperspect.a033118","volume":"10","author":"MG Erkkinen","year":"2018","unstructured":"Erkkinen, M. G., Kim, M.-O. & Geschwind, M. D. Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases. Cold Spring Harb Perspect Biol 10, a033118 (2018).","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"28927_CR2","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma, R. B. et al. MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov. Disord. 30, 1591\u20131601 (2015).","journal-title":"Mov. Disord."},{"key":"28927_CR3","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S1474-4422(05)70285-4","volume":"5","author":"E Tolosa","year":"2006","unstructured":"Tolosa, E., Wenning, G. & Poewe, W. The diagnosis of Parkinson\u2019s disease. Lancet Neurol. 5, 75\u201386 (2006).","journal-title":"Lancet Neurol."},{"key":"28927_CR4","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1093\/ageing\/24.3.210","volume":"24","author":"DF D\u2019Costa","year":"1995","unstructured":"D\u2019Costa, D. F., Sheehan, L. J., Phillips, P. A. & Moore-Smith, B. The levodopa test in Parkinson\u2019s disease. Age Ageing 24, 210\u2013212 (1995).","journal-title":"Age Ageing"},{"key":"28927_CR5","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1001\/jama.2019.22360","volume":"323","author":"MJ Armstrong","year":"2020","unstructured":"Armstrong, M. J. & Okun, M. S. Diagnosis and Treatment of Parkinson Disease: A Review. JAMA 323, 548\u2013560 (2020).","journal-title":"JAMA"},{"key":"28927_CR6","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1002\/mds.1090","volume":"16","author":"JE Ahlskog","year":"2001","unstructured":"Ahlskog, J. E. & Muenter, M. D. Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature. Mov. Disord. 16, 448\u2013458 (2001).","journal-title":"Mov. Disord."},{"key":"28927_CR7","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1002\/mds.22340","volume":"23","author":"CG Goetz","year":"2008","unstructured":"Goetz, C. G. et al. Movement Disorder Society-Sponsored Revision of the Unified Parkinson\u2019s Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results. Mov. Disord. 23, 2129\u20132170 (2008).","journal-title":"Mov. Disord."},{"key":"28927_CR8","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1586\/14737175.4.6.985","volume":"4","author":"C Marras","year":"2004","unstructured":"Marras, C. & Lang, A. E. Outcome measures for clinical trials in Parkinson\u2019s disease: Achievements and shortcomings. Expert Rev Neurother 4, 985\u2013993 (2004).","journal-title":"Expert Rev Neurother"},{"key":"28927_CR9","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1007\/s00415-019-09348-3","volume":"266","author":"A Regnault","year":"2019","unstructured":"Regnault, A. et al. Does the MDS-UPDRS provide the precision to assess progression in early Parkinson\u2019s disease? Learnings from the Parkinson\u2019s progression marker initiative cohort. J Neurol 266, 1927\u20131936 (2019).","journal-title":"J Neurol"},{"key":"28927_CR10","doi-asserted-by":"publisher","first-page":"427","DOI":"10.3233\/JPD-239901","volume":"13","author":"K McFarthing","year":"2023","unstructured":"McFarthing, K. et al. Parkinson\u2019s Disease Drug Therapies in the Clinical Trial Pipeline: 2023 Update. J Parkinsons Dis 13, 427\u2013439 (2023).","journal-title":"J Parkinsons Dis"},{"key":"28927_CR11","doi-asserted-by":"publisher","first-page":"e1001953","DOI":"10.1371\/journal.pmed.1001953","volume":"13","author":"L Piwek","year":"2016","unstructured":"Piwek, L., Ellis, D. A., Andrews, S. & Joinson, A. The Rise of Consumer Health Wearables: Promises and Barriers. PLoS Med 13, e1001953 (2016).","journal-title":"PLoS Med"},{"key":"28927_CR12","doi-asserted-by":"publisher","first-page":"7772","DOI":"10.3390\/s100807772","volume":"10","author":"C-C Yang","year":"2010","unstructured":"Yang, C.-C. & Hsu, Y.-L. A review of accelerometry-based wearable motion detectors for physical activity monitoring. Sensors 10, 7772\u20137788 (2010).","journal-title":"Sensors"},{"key":"28927_CR13","doi-asserted-by":"publisher","first-page":"e0246528","DOI":"10.1371\/journal.pone.0246528","volume":"16","author":"M Sica","year":"2021","unstructured":"Sica, M. et al. Continuous home monitoring of Parkinson\u2019s disease using inertial sensors: A systematic review. PLoS ONE 16, e0246528 (2021).","journal-title":"PLoS ONE"},{"key":"28927_CR14","first-page":"205520762311735","volume":"9","author":"H Zhao","year":"2023","unstructured":"Zhao, H. et al. Wearable sensors and features for diagnosis of neurodegenerative diseases: A systematic review. Digit Health 9, 205520762311735 (2023).","journal-title":"Digit Health"},{"key":"28927_CR15","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/s41531-023-00585-y","volume":"9","author":"C Moreau","year":"2023","unstructured":"Moreau, C. et al. Overview on wearable sensors for the management of Parkinson\u2019s disease. NPJ Parkinsons Dis 9, 153 (2023).","journal-title":"NPJ Parkinsons Dis"},{"key":"28927_CR16","doi-asserted-by":"publisher","first-page":"912343","DOI":"10.3389\/fneur.2022.912343","volume":"13","author":"D Rodr\u00edguez-Mart\u00edn","year":"2022","unstructured":"Rodr\u00edguez-Mart\u00edn, D. et al. A New Paradigm in Parkinson\u2019s Disease Evaluation With Wearable Medical Devices: A Review of STAT-ONTM. Front Neurol 13, 912343 (2022).","journal-title":"Front Neurol"},{"key":"28927_CR17","doi-asserted-by":"publisher","first-page":"S35","DOI":"10.3233\/JPD-202471","volume":"11","author":"S Del Din","year":"2021","unstructured":"Del Din, S., Kirk, C., Yarnall, A. J., Rochester, L. & Hausdorff, J. M. Body-Worn Sensors for Remote Monitoring of Parkinson\u2019s Disease Motor Symptoms: Vision, State of the Art, and Challenges Ahead. J Parkinsons Dis 11, S35\u2013S47 (2021).","journal-title":"J Parkinsons Dis"},{"key":"28927_CR18","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/s41591-022-02159-6","volume":"29","author":"B Kadirvelu","year":"2023","unstructured":"Kadirvelu, B. et al. A wearable motion capture suit and machine learning predict disease progression in Friedreich\u2019s ataxia. Nat Med 29, 86\u201394 (2023).","journal-title":"Nat Med"},{"key":"28927_CR19","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1038\/s41591-023-02459-5","volume":"29","author":"L Servais","year":"2023","unstructured":"Servais, L. et al. First regulatory qualification of a digital primary endpoint to measure treatment efficacy in DMD. Nat Med 29, 2391\u20132392 (2023).","journal-title":"Nat Med"},{"key":"28927_CR20","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1002\/acn3.51281","volume":"8","author":"M Annoussamy","year":"2021","unstructured":"Annoussamy, M. et al. Natural history of Type 2 and 3 spinal muscular atrophy: 2-year NatHis-SMA study. Ann Clin Transl Neurol 8, 359\u2013373 (2021).","journal-title":"Ann Clin Transl Neurol"},{"key":"28927_CR21","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1002\/mus.27446","volume":"65","author":"T Gidaro","year":"2022","unstructured":"Gidaro, T. et al. Home-based gait analysis as an exploratory endpoint during a multicenter phase 1 trial in limb girdle muscular dystrophy type R2 and facioscapulohumeral muscular dystrophy. Muscle Nerve 65, 237\u2013242 (2022).","journal-title":"Muscle Nerve"},{"key":"28927_CR22","doi-asserted-by":"publisher","first-page":"e18907","DOI":"10.2196\/18907","volume":"8","author":"L Lu","year":"2020","unstructured":"Lu, L. et al. Wearable Health Devices in Health Care: Narrative Systematic Review. JMIR Mhealth Uhealth 8, e18907 (2020).","journal-title":"JMIR Mhealth Uhealth"},{"key":"28927_CR23","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41531-020-00136-9","volume":"6","author":"H Woodrow","year":"2020","unstructured":"Woodrow, H. et al. A blinded, controlled trial of objective measurement in Parkinson\u2019s disease. NPJ Parkinsons Dis 6, 35 (2020).","journal-title":"NPJ Parkinsons Dis"},{"key":"28927_CR24","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.gaitpost.2016.08.018","volume":"50","author":"M Capecci","year":"2016","unstructured":"Capecci, M., Pepa, L., Verdini, F. & Ceravolo, M. G. A smartphone-based architecture to detect and quantify freezing of gait in Parkinson\u2019s disease. Gait Posture 50, 28\u201333 (2016).","journal-title":"Gait Posture"},{"key":"28927_CR25","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.gaitpost.2018.03.047","volume":"62","author":"E Stack","year":"2018","unstructured":"Stack, E. et al. Identifying balance impairments in people with Parkinson\u2019s disease using video and wearable sensors. Gait Posture 62, 321\u2013326 (2018).","journal-title":"Gait Posture"},{"key":"28927_CR26","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1111\/j.1755-5949.2011.00253.x","volume":"18","author":"SS Papapetropoulos","year":"2011","unstructured":"Papapetropoulos, S. S. Patient diaries as a clinical endpoint in Parkinson\u2019s disease clinical trials. CNS Neurosci Ther 18, 380\u2013387 (2011).","journal-title":"CNS Neurosci Ther"},{"key":"28927_CR27","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.1038\/s41591-023-02440-2","volume":"29","author":"A-K Schalkamp","year":"2023","unstructured":"Schalkamp, A.-K., Peall, K. J., Harrison, N. A. & Sandor, C. Wearable movement-tracking data identify Parkinson\u2019s disease years before clinical diagnosis. Nat Med 29, 2048\u20132056 (2023).","journal-title":"Nat Med"},{"key":"28927_CR28","unstructured":"European Medicines Agency. EMA qualification opinion for SV95C as primary endpoint in studies in ambulatory Duchenne Muscular Dystrophy studies. https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/qualification-opinion-stride-velocity-95th-centile-primary-endpoint-studies-ambulatory-duchenne-muscular-dystrophy-studies_en.pdf."},{"key":"28927_CR29","doi-asserted-by":"publisher","first-page":"5214","DOI":"10.1212\/WNL.0000000000205650","volume":"102","author":"M Poleur","year":"2024","unstructured":"Poleur, M. et al. Digital Outcome Measure Assessing the Motor Function of Patients with Amyotrophic Lateral Sclerosis. Neurology 102, 5214 (2024).","journal-title":"Neurology"},{"key":"28927_CR30","doi-asserted-by":"publisher","first-page":"5890","DOI":"10.1212\/WNL.0000000000206099","volume":"102","author":"M Poleur","year":"2024","unstructured":"Poleur, M. et al. Reliability and External Validity of Digital Passive Gait Tracking in MS. Neurology 102, 5890 (2024).","journal-title":"Neurology"},{"key":"28927_CR31","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1002\/mds.27671","volume":"34","author":"AJ Espay","year":"2019","unstructured":"Espay, A. J. et al. A roadmap for implementation of patient-centered digital outcome measures in Parkinson\u2019s disease obtained using mobile health technologies. Mov Disord 34, 657\u2013663 (2019).","journal-title":"Mov Disord"},{"key":"28927_CR32","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1002\/mdc3.12921","volume":"7","author":"S Schade","year":"2020","unstructured":"Schade, S., Mollenhauer, B. & Trenkwalder, C. Levodopa Equivalent Dose Conversion Factors: An Updated Proposal Including Opicapone and Safinamide. Mov Disord Clin Pract 7, 343\u2013345 (2020).","journal-title":"Mov Disord Clin Pract"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-28927-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-28927-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-28927-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T19:02:55Z","timestamp":1777402975000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-28927-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,27]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["28927"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-28927-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,27]]},"assertion":[{"value":"14 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"45479"}}